Chromosomal stability of mesenchymal stromal cells during in vitro culture.

Cytotherapy

Division of Cell and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA. Electronic address:

Published: March 2016

Background Aims: Mesenchymal stromal cells (MSCs) are being investigated for use in cell therapy. The extensive in vitro expansion necessary to obtain sufficient cells for clinical use increases the risk that genetically abnormal cells will arise and be propagated during cell culture. Genetic abnormalities may lead to transformation and poor performance in clinical use, and are a critical safety concern for cell therapies using MSCs.

Methods: We used spectral karyotyping (SKY) to investigate the genetic stability of human MSCs from ten donors during passaging.

Results: Our data indicate that chromosomal abnormalities exist in MSCs at early passages and can be clonally propagated. The karyotypic abnormalities observed during our study diminished during passage.

Conclusions: Karyotyping of MSCs reveals characteristics which may be valuable in deciding the suitability of cells for further use. Karyotypic analysis is useful for monitoring the genetic stability of MSCs during expansion.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516473PMC
http://dx.doi.org/10.1016/j.jcyt.2015.11.017DOI Listing

Publication Analysis

Top Keywords

mesenchymal stromal
8
stromal cells
8
genetic stability
8
cells
5
mscs
5
chromosomal stability
4
stability mesenchymal
4
cells vitro
4
vitro culture
4
culture background
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!